Výsledky vyhledávání - "Z. Barmparessou"

Akademický článek

Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19.

Autor: Aggarwal NR; Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA., Nordwall J; Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA., Braun DL; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Chung L; CAMRIS International (under contract no. 75N93019D00025 with National Institute of Allergy and Infectious Diseases, Department of Health and Human Services), National Institute of Health, Bethesda, Maryland, USA., Coslet J; Velocity Clinical Research, Chula Vista, California, USA., Der T; Department of General Internal Medicine, Duke University School of Medicine, Durham, North Carolina, USA., Eriobu N; Institute of Human Virology Nigeria, Abuja, Nigeria., Ginde AA; Department of Emergency Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA., Hayanga AJ; Department of Cardiovascular Thoracic Surgery, West Virginia University School of Medicine, Morgantown, West Virginia, USA., Highbarger H; Virus Isolation and Serology Laboratory, Frederick National Laboratory, National Cancer Institute, Frederick, Maryland, USA., Holodniy M; Veterans Affairs Palo Alto Health Care System, Division of Infectious Diseases and Geographic Medicine, Stanford University, Palo Alto, California, USA., Horcajada JP; Department of Infectious Diseases, Hospital del Mar Research Insititute, UPF, Barcelona, Spain.; CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain., Jain MK; Division of Infectious Diseases and Geotropical Medicine, UT Southwestern Medical Center and Parkland Health and Hospital System, Dallas, Texas, USA., Kim K; Division of Infectious Disease and International Medicine, Morsani College of Medicine, University of South Florida and Global Emerging Diseases Institute, Tampa General Hospital, Tampa, Florida, USA., Laverdure S; Laboratory of Human Retrovirology and Immunoinformatics, Frederick National Laboratory, National Cancer Institute, Frederick, Maryland, USA., Lundgren J; CHIP Center of Excellence for Health, Immunity, and Infections and Department of Infectious Diseases, Righospitalet, University of Copenhagen, Copenhagen, Denmark., Natarajan V; Laboratory of Molecular Cell Biology, Frederick National Laboratory, National Cancer Institute, Frederick, Maryland, USA., Nguyen HH; Division of Infectious Diseases, Veterans Affairs Northern California, University of California, Davis, Sacramento, California, USA., Pett SL; The Medical Research Council Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, United Kingdom.; Institute for Global Health, University College London, London, United Kingdom., Phillips A; Institute for Global Health, University College London, London, United Kingdom., Poulakou G; Third Department of Medicine and Laboratory National and Kapodistrian University of Athens Medical School, Athens, Greece., Price DA; Newcastle Upon Tyne NHUS Hospitals Foundation Trust, Newcastle Upon Tyne, United Kingdom., Robinson P; Infection Prevention and Hospital Epidemiology, Hoag Memorial Hospital Presbyterian, Newport Beach, California, USA., Rogers AJ; Division of Pulmonary, Allergy, and Critical Care Medicine, Stanford University, Palo Alto, California, USA., Sandkovsky U; Division of Infectious Diseases, Baylor University Medical Center, Dallas, Texas, USA., Shaw-Saliba K; National Institute of Allergy and Infectious Diseases/National Institutes of Health, Bethesda, Maryland, USA., Sturek JM; Division of Pulmonary and Critical Care Medicine, Department of Medicine, UVA Health, Charlottesville, Virginia, USA., Trautner BW; Michael E. DeBakey Veterans Affairs Medical Center, Baylor College of Medicine, Houston, Texas, USA., Waters M; Velocity Clinical Research, Chula Vista, California, USA., Reilly C; Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Jun 14; Vol. 78 (6), pp. 1490-1503.

Zobrazit plný text záznamu

Akademický článek

Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19.

Autor: Jensen TO; Centre of Excellence for Health, Immunity, and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Grandits GA; Division of Biostatistics, University of Minnesota, Minneapolis, Minnesota, USA., Jain MK; Southwestern Medical Center, University of Texas, Dallas, Texas USA., Murray TA; Division of Biostatistics, University of Minnesota, Minneapolis, Minnesota, USA., Grund B; School of Statistics, University of Minnesota, Minneapolis, Minnesota, USA., Shaw-Saliba K; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Matthay MA; Division of Pulmonary and Critical Care Medicine, University of California SanFrancisco, San Francisco, California, USA., Abassi M; Division of Infectious Diseases and International Medicine, University of Minnesota, Minneapolis, Minnesota, USA., Ardelt M; Division of Pulmonary and Critical Care Medicine, University of California SanFrancisco, San Francisco, California, USA., Baker JV; Division of Infectious Diseases and International Medicine, University of Minnesota, Minneapolis, Minnesota, USA.; Division of Infectious Diseases, Hennepin Healthcare, Minneapolis, Minnesota, USA., Chen P; Women's Guild Lung Institute, Department of medicine and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA., Dewar RL; Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Goodman AL; Medical Research Council Clinical Trials Unit, University College London, London, United Kingdom.; Department of Infectious Diseases, Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom., Hatlen TJ; Lundquist Institute, Harbor-University of California Los Angeles Medical Center, Torrance, California, USA., Highbarger HC; Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Holodniy M; Department of Medicine, Infectious Diseases, Stanford University, Stanford, California, USA.; Veterans Affairs Palo Alto Health Care System, Palo Alto, California, USA., Lallemand P; Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Laverdure S; Laboratory of Human Retrovirology and Immunoinformatics, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Leshnower BG; Division of Cardiothoracic Surgery, Emory School of Medicine, Atlanta, Georgia, USA., Looney D; Division of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, California, USA., Moschopoulos CD; School of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Mugerwa H; Joint Clinical Research Centre, Kampala, Uganda., Murray DD; Centre of Excellence for Health, Immunity, and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Mylonakis E; Department of Medicine, Houston Methodist Hospital, Houston, Texas, USA., Nagy-Agren S; Salem Veterans Affairs Medical Center, Virginia, USA.; Virginia Tech Carilion School of Medicine, Virginia, USA., Rehman MT; Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Rupert A; Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Stevens RA; Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Turville S; The Kirby Institute, University of New South Wales, Sydney, Australia., Weintrob A; Infectious Diseases Section, Washington DC Veterans Affairs Medical Center, Washington, District of Columbia, USA., Wick K; Department of Internal Medicine, University of California Davis, Davis, California, USA., Lundgren J; Centre of Excellence for Health, Immunity, and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Ko ER; Division of General Internal Medicine, Department of Medicine, Duke University Health System, Durham, North Carolina, USA.

Publikováno v: The Journal of infectious diseases [J Infect Dis] 2024 Mar 14; Vol. 229 (3), pp. 671-679.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání